Psikofarmaka Medications in Influencing Mental Activity and Behavior Through Selective Action on the Central Nervous System : Article Study

Authors

  • Fendy Prasetyawan Universitas Kadiri
  • Achmad Wahdi Universitas Kadiri
  • Yuneka Saristiana Universitas Kadiri
  • Dewi Retno Puspitasari STIKes Ganesha Husada Kediri

DOI:

https://doi.org/10.59890/ijaep.v1i2.8862

Keywords:

Psikofarmaka, Mental Activity, Central Nervous System

Abstract

Psychotropic drugs are pivotal in managing a spectrum of mental health disorders, operating by selectively modulating the central nervous system (CNS). The CNS serves as the primary target for psychotropic drugs, where they modulate neurotransmitter systems to regulate neural activity and influence behavior. Understanding the neurobiological mechanisms underlying these medications is crucial for enhancing treatment efficacy and minimizing adverse effects. Psychotropic medications encompass various classes, each with distinct mechanisms and clinical applications. While these drugs demonstrate therapeutic efficacy, challenges persist in achieving optimal treatment outcomes, including medication adherence and managing side effects. Regulations play a vital role in ensuring the safe and appropriate use of psychotropic drugs. They encompass monitoring prescription and dispensing practices, categorizing drugs based on their abuse potential, and emphasizing patient education and informed consent. By adhering to stringent regulations and promoting ethical prescribing practices, the healthcare system aims to mitigate the risks associated with psychotropic medications while maximizing their therapeutic benefits.

Downloads

Download data is not yet available.

References

Azab, M., Novella, A., Ianes, A., & Pasina, L. (2024). Potentially Inappropriate Psychotropic Drugs in Nursing Homes: An Italian Observational Study. Drugs & Aging, 41(2), 187-197.

Boehnke, T., Franke, C., Bauerfeind, A., Heinemann, K., Kolberg-Liedtke, C., & Koelkebeck, K. (2024). Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across twelve European countries. Contraception, 110375.

De Kuijper, G., Jonker, J., Sheehan, R., & Hassiotis, A. (2024). A survey on service users' perspectives about information and shared decision‐making in psychotropic drug prescriptions in people with intellectual disabilities. British Journal of Learning Disabilities.

Dégardin, K., Guillemain, A., Feng, A., Saladin, C., Paratte, S., Zurbach, R., & Mohn, T. (2024). Forensic analysis of counterfeit psychotropic drugs. Talanta Open, 100295.

Du, J., Burger, H., Kupers, T., Sulim, K., Homburg, M. T., Muris, J. W., ... & Janus, S. I. (2024). Patterns of psychotropic drug prescriptions and general practice consultations among community-dwelling older people with dementia during the first two years of the COVID-19 pandemic. BMC geriatrics, 24(1), 1-14.

Frank, R. G., Conti, R. M., & Goldman, H. H. (2005). Mental health policy and psychotropic drugs. The Milbank Quarterly, 83(2), 271-298.

Grover, S., Chakrabarti, S., Sharma, A., & Tyagi, S. (2014). Attitudes toward psychotropic medications among patients with chronic psychiatric disorders and their family caregivers. Journal of neurosciences in rural practice, 5(04), 374-383.

Hailemariam, M., Bustos, T. E., Montgomery, B. W., Brown, G., Tefera, G., Adaji, R., ... & Johnson, J. E. (2024). Mental health interventions for individuals with serious mental illness in the criminal legal system: a systematic review. BMC psychiatry, 24(1), 199.

Huang, X., Harris, L. M., Funsch, K. M., Fox, K. R., & Ribeiro, J. D. (2022). Efficacy of psychotropic medications on suicide and self-injury: a meta-analysis of randomized controlled trials. Translational psychiatry, 12(1), 400.

Kreek, M. J., LaForge, K. S., & Butelman, E. (2002). Pharmacotherapy of addictions. Nature reviews Drug discovery, 1(9), 710-726.

McIntyre, R. S., Kwan, A. T., Rosenblat, J. D., Teopiz, K. M., & Mansur, R. B. (2024). Psychotropic Drug–Related Weight Gain and Its Treatment. American Journal of Psychiatry, 181(1), 26-38.

Parry, H. J. (1968). Use of psychotropic drugs by US adults. Public Health Reports, 83(10), 799.

Raffi, E. R., Nonacs, R., & Cohen, L. S. (2019). Safety of psychotropic medications during pregnancy. Clinics in Perinatology, 46(2), 215-234.

Serapinas, D., & Narbekovas, A. (2024). -Bioethical Considerations for COMT gene Polymorphisms Testing in Psychotropic Drug Users. Psychoneuroendocrinology, 160, 106892.

Wicaksono, A.B., (2023). Mengenal Obat-Obatan Jiwa (Psikofarmaka). Kemenkes : Direktorat Jenderal Pelayanan Kesehatan. Citited at April 20, 2024. https://yankes.kemkes.go.id/view_artikel/2155/mengenal-obat-obatan-jiwa-psikofarmaka.

Downloads

Published

2024-04-30

How to Cite

Prasetyawan, F. ., Wahdi, A. ., Saristiana, Y. ., & Retno Puspitasari, D. . (2024). Psikofarmaka Medications in Influencing Mental Activity and Behavior Through Selective Action on the Central Nervous System : Article Study. International Journal of Asian Education and Psychology, 1(2). https://doi.org/10.59890/ijaep.v1i2.8862

Issue

Section

Articles